SCHEMBL29974991

SCHEMBL29974991

COc1cc(N2CCN(C)CC2)c(N)cc1Nc1ncc(C)c(-c2c[nH]c3ccccc23)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.63
▸ IGF1R P08069 3/20 0.56
▸ KCNH2 Q12809 1/20 0.56
▸ ALK Q9UM73 1/20 0.54
▸ JAK1 P23458 2/20 0.53
▸ JAK2 O60674 1/20 0.53
▸ TNK2 Q07912 3/20 0.47
▸ CDK2 P24941 2/20 0.46
▸ DYRK1B Q9Y463 2/20 0.46
▸ CCNT1 O60563 1/20 0.45
▸ CCNK O75909 1/20 0.45
▸ CDK7 P50613 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ CCNH P51946 1/20 0.45
▸ MNAT1 P51948 1/20 0.45
▸ CDK12 Q9NYV4 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ JUN P05412 1/20 0.45
▸ MAPK8 P45983 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14663383 1.00 EGFR (0.63) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL23294110 0.94 EGFR (0.61) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL29232072 0.91 ALK (0.57) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL30956842 0.91 ALK (0.57) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL29974570 0.91 EGFR (0.74) EGFRIGF1RKCNH2ALKCDK2
SCHEMBL14663439 0.91 EGFR (0.74) EGFRIGF1RKCNH2ALKCDK2
SCHEMBL14663329 0.89 EGFR (0.60) EGFRIGF1RKCNH2ALKTNK2
SCHEMBL14718523 0.87 EGFR (0.61) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL517589 0.86 EGFR (0.69) EGFRIGF1RKCNH2ALKJAK1
SCHEMBL14719022 0.85 EGFR (0.74) EGFRIGF1RKCNH2CDK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4086246-A1 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS AS EGFR MODULATORS AstraZeneca AB (SE) 2022-11-09 — — EP disclosed
Send feedback